Calcipotriene for psoriasis
Medical Letter on Drugs and Therapeutics 36(928): 70-71
1994
ISSN/ISBN: 0025-732X PMID: 8035754 Document Number: 438511
Document emailed within 1 workday
Related Documents
Kirsner, R.S.; Federman, D. 1995: Treatment of psoriasis: role of calcipotriene American Family Physician 52(1): 237-240; 243-244Menter, A.; Abramovits, W.; Colón, L.E.; Johnson, L.A.; Gottschalk, R.W. 2009: Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis Journal of Drugs in Dermatology: Jdd 8(1): 52-57
Menter, A.; Gold, L.S.; Bukhalo, M.; Grekin, S.; Kempers, S.; Boyce, B.M.; Ganslandt, C.; Villumsen, J.; Lebwohl, M. 2013: Calcipotriene plus betamethasone dipropionate topical suspension for the treatment of mild to moderate psoriasis vulgaris on the body: a randomized, double-blind, vehicle-controlled trial Journal of Drugs in Dermatology: Jdd 12(1): 92-98
Kircik, L.H. 2011: Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial Journal of Drugs in Dermatology: Jdd 10(8): 878-882
Bhatia, N.; Kircik, L. 2018: Clobetasol Emulsion Foam and Calcipotriene 0.005% Foam Combination Therapy for the Maintenance of Treatment Response in Patients with Moderate Plaque Psoriasis Journal of Drugs in Dermatology: Jdd 17(3): 342-346
Feldman, S.R.; Mills, M.; Brundage, T.; Eastman, W.J. 2013: A multicenter, randomized, double-blind study of the efficacy and safety of calcipotriene foam, 0.005%, vs vehicle foam in the treatment of plaque-type psoriasis of the scalp Journal of Drugs in Dermatology: Jdd 12(3): 300-306
Leonardi, C.; Bagel, J.; Yamauchi, P.; Pariser, D.; Xu, Z.; Moller, A.; Osterdal, M.L.; Stein Gold, L. 2016: The Aerosol Foam Formulation of the Fixed Combination Calcipotriene Plus Betamethasone Dipropionate Improves the Health-Related Quality of Life in Patients with Psoriasis Vulgaris: Results from the Randomized PSO-FAST Study Journal of Drugs in Dermatology: Jdd 15(8): 981-987
Silver, S.; Tuppal, R.; Gupta, A.K.; Clonier, F.; Olesen, M.; Leeder, R.; Taraska, V. 2013: Effect of calcipotriene plus betamethasone dipropionate topical suspension on the hypothalamic-pituitary-adrenal axis and calcium homeostasis in subjects with extensive psoriasis vulgaris: an open, non-controlled, 8-week trial Journal of Drugs in Dermatology: Jdd 12(8): 882-887
Deliduka, S.B.; Kwong, P.C. 2004: Treatment of Nevus comedonicus with topical tazarotene and calcipotriene Journal of Drugs in Dermatology: Jdd 3(6): 674-676
Bonomo, L.; Abittan, B.J..; Hashim, P.W..; Karki, C.; Mason, M.; Lebwohl, M. 2019: Combination use of Systemic Therapies in Psoriasis: Baseline Characteristics from the Corrona Psoriasis Registry Journal of Drugs in Dermatology: Jdd 18(8): 731-740
Miemiec, E. 1970: Quantitative determination of IgM in serum of patients with psoriasis vulgaris with respect to psoriasis arthropathica Dermatologische Monatschrift 156(5): 490-492
Hellgren, L. 1976: Induction of generalized pustular psoriasis by topical use of betamethasone-dipropionate ointment in psoriasis Annals of Clinical Research 8(5): 317-319
Kwan, Z.; Yeoh, C.A.; Mohd Affandi, A.; Alias, F.A.; Hamid, M.; Baharum, N.; Yong, A.S.W.; Baba, R. 2015: Causes of mortality in patients with psoriasis in Malaysia - Evidence from the Malaysian Psoriasis Registry Medical Journal of Malaysia 70(5): 273-277
Wong, J.W.; Kamangar, F.; Nguyen, T.V.; Koo, J.Y.M. 2012: Excimer laser therapy for hairline psoriasis: a useful addition to the scalp psoriasis treatment algorithm Skin Therapy Letter 17(5): 6-9
Chowaniec, O.; Blichowska, T. 1979: Case of generalized pustular psoriasis caused by corticosteroid treatment of simple psoriasis and pemphigus Przeglad Dermatologiczny 66(5): 541-544
Au, S-Chung.; Madani, A.; Alhaddad, M.; Alkofide, M.; Gottlieb, A.B. 2013: Comparison of the efficacy of biologics versus conventional systemic therapies in the treatment of psoriasis at a comprehensive psoriasis care center Journal of drugs in dermatology: JDD 12(8): 861-866
Furukawa, F.; Imamura, S.; Yasuda, H.; Ohkawara, A. 1993: Pustular psoriasis and psoriasis vulgaris Nihon Rinsho. Japanese Journal of Clinical Medicine 51 Suppl: 976-981
Balevi, A.; Olmuşçelik, O.; Ustuner, P.; Özdemir, M. 2018: Is there any Correlation between Red Cell Distribution Width, Mean Platelet Volume Neutrophil Count, Lymphocyte Count, and Psoriasis Area Severity Index in Patients Under Treatment for Psoriasis? Acta Dermatovenerologica Croatica: Adc 26(3): 199-205
Feldman, S.R. 2014: Psoriasis: the new and the old Journal of Drugs in Dermatology: Jdd 13(8): 894
Dobson, R.L. 1980: The inheritance of psoriasis Archives of Dermatology 116(6): 657